ATH 0.00% 0.5¢ alterity therapeutics limited

ABRUPT, IMMEDIATE DEPARTURE OF BILLY DUNN, FDA NEUROSCIENCE CHIEF

  1. 186 Posts.
    lightbulb Created with Sketch. 50
    Breaking news today on ENDPOINTS NEWS.COM. Apart from me, is anyone else suspicious about this? He has been recently accused of being a bit too close to Big Pharma Companies such as Pfizer and Biogen. I don't know how long he was with the FDA , but I would hate to think he was there when PBT2 was rejected for "poor trial design" and the bogus "dog studies debacle." With his dubious integrity perhaps in question, I guess we shouldn't hire him to lead our new company that MAY BE FORMED to pursue PBT2 for both antibiotic resistance and Alzheimer's Disease?! Regardless of honesty and integrity being rather important, how would we pay such a high-powered, experienced, neuroscience "expert?" Maybe Billy will show up soon with a new job at Pfizer, Biogen, or even with "The FUND"! I sure hope not...
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.6¢ 0.5¢ $6.597K 1.228M

Buyers (Bids)

No. Vol. Price($)
46 43063865 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 20756597 18
View Market Depth
Last trade - 16.10pm 16/05/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
0.5¢ 0.6¢ 0.5¢ 657500
Last updated 15.45pm 16/05/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.